Research Paper Volume 13, Issue 14 pp 18701—18717

Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma


Figure 6. Relationships between the risk assessment score expression and clinicopathological factors in LUAD. (A) Heatmap of the epigenetic-related genes expression in the high and low risk groups and the clinicopathologic differences between the two groups. (B) Boxplots show the risk assessment score of patients with different pathological stage, T_stage, N_ stage and growth pattern. Univariate (C) and multivariate (D) independent prognostic analysis of independent risk factors for overall survival (OS) in patients with LUAD.